Skip to content

Effect of temporal interference stimulation on consciousness recovery in patients with prolonged disorders of consciousness

Transcranial temporal interference stimulation for prolonged disorders of consciousness: a phase 1 feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099541
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term impaired consciousness

Interventions

tTIS group:tTIS and regular treatment

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years old; 2. Patients who are clinically diagnosed with vegetative state or microconscious state by CRS-R scale score; 3. The course of the disease >=28 days but < 1 year; 4. The cause is severe acquired brain injury; 5. The patient's legal guardian signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with internal implants incompatible with MRI scanning systems; 2. Patients in deep sedation; 3. Patients with a history of severe central nervous system developmental abnormalities, severe neurologic or psychiatric disorders or substance use, e.g., mental retardation, prior severe craniocerebral injury, epilepsy; 4. Patients with a documented seizure within the last 1 month after insult; 5. pregnant women; 6. Patients with organ dysfunction; 7. Patients with hyperthermia; 8. Patients with infection; 9. Patients with uncontrolled severe hypertension or other major complications; 10. Patients with acute myocardial infarction; 11. Patients with acute pulmonary embolism; 12. Patients with deep vein thrombosis; 13. Patients with other clinically critical states such as severe anaemia; 14. Patients with concurrent participation in other clinical trials; 15. Patients at high risk of high risk but with low benefit from the tTIS intervention, assessed by the principal investigator (PI).

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale-Revised;AE, SAE;Glasgow Coma Scale;Full Outline of UnResponsiveness;Glasgow Outcome Scale-Extended;Disability Rating Scale;

Secondary

MeasureTime frame
EEG and fMRI;

Countries

China

Contacts

Public ContactXiao Lu

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

luxiao1972@163.com+86 25 83718836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026